{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:57:24Z","timestamp":1781704644532,"version":"3.54.5"},"reference-count":43,"publisher":"Norwegian Medical Association","issue":"19","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Tidsskr Nor Legeforen","Tidsskriftet"],"DOI":"10.4045\/tidsskr.17.0595","type":"journal-article","created":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T04:57:07Z","timestamp":1543553827000},"source":"Crossref","is-referenced-by-count":0,"title":["Dopa-responsive dystonia"],"prefix":"10.4045","volume":"138","author":[{"given":"Hans","family":"Randby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathrin Lytomt","family":"Salvador","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Oppeb\u00f8en","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger Marie","family":"Skogseid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanette","family":"Koht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2479","published-online":{"date-parts":[[2018,11,26]]},"reference":[{"key":"ref=1","doi-asserted-by":"crossref","unstructured":"Albanese\u00a0A, Bhatia\u00a0K, Bressman\u00a0SB et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013; 28: 863\u201373. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23649720&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fmds.25475","DOI":"10.1002\/mds.25475"},{"key":"ref=2","doi-asserted-by":"crossref","unstructured":"Friedman\u00a0JR. What is not in the name? Doparesponsive dystonia may respond to more than l-dopa. Pediatr Neurol 2016; 59: 76\u201380. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27080360&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.pediatrneurol.2015.12.016","DOI":"10.1016\/j.pediatrneurol.2015.12.016"},{"key":"ref=3","doi-asserted-by":"crossref","unstructured":"Wijemanne\u00a0S, Jankovic\u00a0J. Dopa-responsive dystonia\u2013clinical and genetic heterogeneity. Nat Rev Neurol 2015; 11: 414\u201324. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26100751&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038%2Fnrneurol.2015.86","DOI":"10.1038\/nrneurol.2015.86"},{"key":"ref=4","doi-asserted-by":"crossref","unstructured":"Furukawa\u00a0Y, Rajput\u00a0AH, Tong\u00a0J et al. A marked contrast between serotonergic and dopaminergic changes in dopa-responsive dystonia. Neurology 2016; 87: 1060\u20131. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27488599&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1212%2FWNL.0000000000003065","DOI":"10.1212\/WNL.0000000000003065"},{"key":"ref=5","doi-asserted-by":"crossref","unstructured":"Ng\u00a0J, Papandreou\u00a0A, Heales\u00a0SJ et al. Monoamine neurotransmitter disorders\u2013clinical advances and future perspectives. Nat Rev Neurol 2015; 11: 567\u201384. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26392380&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1038%2Fnrneurol.2015.172","DOI":"10.1038\/nrneurol.2015.172"},{"key":"ref=6","unstructured":"Blau NH, Georg F. red. Congenital Neurotransmitter Disorders \u2013 A Clinical Approach. US, New York, NY: Nova Science Publishers Inc, 2015."},{"key":"ref=7","unstructured":"Furukawa Y. GTP cyclohydrolase 1-deficient doparesponsive dystonia. Seattle, WA: Gene Reviews, NCBI, 2015. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1508\/ (31.8.2018)."},{"key":"ref=8","unstructured":"Dystonia, doparesponsive; DRD. OMIM \u2013 Online Mendelian Inheritance in Man. http:\/\/www.omim.org\/entry\/128230 (31.8.2018)."},{"key":"ref=9","unstructured":"Segawa\u00a0M, Hosaka\u00a0A, Miyagawa\u00a0F et al. Hereditary progressive dystonia with marked diurnal fluctuation. Adv Neurol 1976; 14: 215\u201333. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=945938&dopt=Abstract"},{"key":"ref=10","unstructured":"Nygaard\u00a0TG, Marsden\u00a0CD, Duvoisin\u00a0RC. Dopa-responsive dystonia. Adv Neurol 1988; 50: 377\u201384. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=3041760&dopt=Abstract"},{"key":"ref=11","unstructured":"Lee\u00a0WW, Jeon\u00a0BS. Clinical spectrum of dopa-responsive dystonia and related disorders. Curr Neurol Neurosci Rep 2014; 14: 461. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24844652&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs11910-014-0461-9"},{"key":"ref=12","doi-asserted-by":"crossref","unstructured":"Malek\u00a0N, Fletcher\u00a0N, Newman\u00a0E. Diagnosing dopamine-responsive dystonias. Pract Neurol 2015; 15: 340\u20135. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=26045581&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fpractneurol-2015-001101","DOI":"10.1136\/practneurol-2015-001101"},{"key":"ref=13","unstructured":"Nygaard\u00a0TG. Dopa-responsive dystonia. Curr Opin Neurol 1995; 8: 310\u20133. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=7582048&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1097%2F00019052-199508000-00011"},{"key":"ref=14","doi-asserted-by":"crossref","unstructured":"Koht\u00a0J, Rengmark\u00a0A, Opladen\u00a0T et al. Clinical and genetic studies in a family with a novel mutation in the sepiapterin reductase gene. Acta Neurol Scand Suppl 2014; 129: 7\u201312. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24588500&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1111%2Fane.12230","DOI":"10.1111\/ane.12230"},{"key":"ref=15","doi-asserted-by":"crossref","unstructured":"Haugarvoll\u00a0K, Bindoff\u00a0LA. A novel compound heterozygous tyrosine hydroxylase mutation (p.R441P) with complex phenotype. J Parkinsons Dis 2011; 1: 119\u201322. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23939262&dopt=Abstract","DOI":"10.3233\/JPD-2011-11006"},{"key":"ref=16","unstructured":"Farbu\u00a0E, Bindoff\u00a0LA. Doparesponsiv dystoni\u2013en arvelig dystoni som er lett \u00e5 behandle. Tidsskr Nor Laegeforen 2002; 122: 379\u201381. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11915666&dopt=Abstract"},{"key":"ref=17","doi-asserted-by":"crossref","unstructured":"Br\u00fcggemann\u00a0N, Stiller\u00a0S, Tadic\u00a0V et al. Non-motor phenotype of dopa-responsive dystonia and quality of life assessment. Parkinsonism Relat Disord 2014; 20: 428\u201331. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=24444533&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.parkreldis.2013.12.014","DOI":"10.1016\/j.parkreldis.2013.12.014"},{"key":"ref=18","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Laso\u00a0E, S\u00e1nchez-Raya\u00a0A, Moriana\u00a0JA et al. Neuropsychiatric symptoms and intelligence quotient in autosomal dominant Segawa disease. J Neurol 2011; 258: 2155\u201362. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=21556877&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs00415-011-6079-9","DOI":"10.1007\/s00415-011-6079-9"},{"key":"ref=19","doi-asserted-by":"crossref","unstructured":"Tadic\u00a0V, Kasten\u00a0M, Br\u00fcggemann\u00a0N et al. Dopa-responsive dystonia revisited: diagnostic delay, residual signs, and nonmotor signs. Arch Neurol 2012; 69: 1558\u201362. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22986512&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1001%2Farchneurol.2012.574","DOI":"10.1001\/archneurol.2012.574"},{"key":"ref=20","doi-asserted-by":"crossref","unstructured":"Naiya\u00a0T, Misra\u00a0AK, Biswas\u00a0A et al. Occurrence of GCH1 gene mutations in a group of Indian dystonia patients. J Neural Transm (Vienna) 2012; 119: 1343\u201350. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22373569&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs00702-012-0777-z","DOI":"10.1007\/s00702-012-0777-z"},{"key":"ref=21","doi-asserted-by":"crossref","unstructured":"Uncini\u00a0A, De Angelis\u00a0MV, Di Fulvio\u00a0P et al. Wide expressivity variation and high but no gender-related penetrance in two dopa-responsive dystonia families with a novel GCH-I mutation. Mov Disord 2004; 19: 1139\u201345. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=15390021&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fmds.20048","DOI":"10.1002\/mds.20048"},{"key":"ref=22","unstructured":"Friedman\u00a0J, Roze\u00a0E, Abdenur\u00a0JE et al. Sepiapterin reductase deficiency: a treatable mimic of cerebral palsy. Ann Neurol 2012; 71: 520\u201330. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22522443&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fana.22685"},{"key":"ref=23","doi-asserted-by":"crossref","unstructured":"Opladen\u00a0T, Hoffmann\u00a0G, H\u00f6rster\u00a0F et al. Clinical and biochemical characterization of patients with early infantile onset of autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia. Mov Disord 2011; 26: 157\u201361. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20818608&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fmds.23329","DOI":"10.1002\/mds.23329"},{"key":"ref=24","doi-asserted-by":"crossref","unstructured":"Pearl\u00a0PL, Hartka\u00a0TR, Taylor\u00a0J. Diagnosis and treatment of neurotransmitter disorders. Curr Treat Options Neurol 2006; 8: 441\u201350. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17032564&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs11940-006-0033-7","DOI":"10.1007\/s11940-006-0033-7"},{"key":"ref=25","doi-asserted-by":"crossref","unstructured":"Clot\u00a0F, Grabli\u00a0D, Cazeneuve\u00a0C et al. Exhaustive analysis of BH4 and dopamine biosynthesis genes in patients with Dopa-responsive dystonia. Brain 2009; 132: 1753\u201363. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19491146&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1093%2Fbrain%2Fawp084","DOI":"10.1093\/brain\/awp084"},{"key":"ref=26","doi-asserted-by":"crossref","unstructured":"Trender-Gerhard\u00a0I, Sweeney\u00a0MG, Schwingenschuh\u00a0P et al. Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients. J Neurol Neurosurg Psychiatry 2009; 80: 839\u201345. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=19332422&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fjnnp.2008.155861","DOI":"10.1136\/jnnp.2008.155861"},{"key":"ref=27","doi-asserted-by":"crossref","unstructured":"Low\u00a0K, Harding\u00a0T, Jardine\u00a0P. Dopa responsive dystonia. BMJ 2010; 340: c668. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20203076&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1136%2Fbmj.c668","DOI":"10.1136\/bmj.c668"},{"key":"ref=28","doi-asserted-by":"crossref","unstructured":"Ng\u00a0J, Heales\u00a0SJ, Kurian\u00a0MA. Clinical features and pharmacotherapy of childhood monoamine neurotransmitter disorders. Paediatr Drugs 2014; 16: 275\u201391. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=25011953&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs40272-014-0079-z","DOI":"10.1007\/s40272-014-0079-z"},{"key":"ref=29","doi-asserted-by":"crossref","unstructured":"Segawa\u00a0M, Nomura\u00a0Y, Nishiyama\u00a0N. Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease). Ann Neurol 2003; 54 (suppl 6): S32\u201345. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12891652&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fana.10630","DOI":"10.1002\/ana.10630"},{"key":"ref=30","doi-asserted-by":"crossref","unstructured":"Horvath\u00a0GA, Stockler-Ipsiroglu\u00a0SG, Salvarinova-Zivkovic\u00a0R et al. Autosomal recessive GTP cyclohydrolase I deficiency without hyperphenylalaninemia: evidence of a phenotypic continuum between dominant and recessive forms. Mol Genet Metab 2008; 94: 127\u201331. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=18276179&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.ymgme.2008.01.003","DOI":"10.1016\/j.ymgme.2008.01.003"},{"key":"ref=31","doi-asserted-by":"crossref","unstructured":"Nardocci\u00a0N, Zorzi\u00a0G, Blau\u00a0N et al. Neonatal dopa-responsive extrapyramidal syndrome in twins with recessive GTPCH deficiency. Neurology 2003; 60: 335\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12552057&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1212%2F01.WNL.0000044049.99690.AD","DOI":"10.1212\/01.WNL.0000044049.99690.AD"},{"key":"ref=32","doi-asserted-by":"crossref","unstructured":"Willemsen\u00a0MA, Verbeek\u00a0MM, Kamsteeg\u00a0EJ et al. Tyrosine hydroxylase deficiency: a treatable disorder of brain catecholamine biosynthesis. Brain 2010; 133: 1810\u201322. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20430833&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1093%2Fbrain%2Fawq087","DOI":"10.1093\/brain\/awq087"},{"key":"ref=33","doi-asserted-by":"crossref","unstructured":"Hoffmann\u00a0GF, Assmann\u00a0B, Br\u00e4utigam\u00a0C et al. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Ann Neurol 2003; 54 (suppl 6): S56\u201365. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12891655&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1002%2Fana.10632","DOI":"10.1002\/ana.10632"},{"key":"ref=34","doi-asserted-by":"crossref","unstructured":"Bonaf\u00e9\u00a0L, Th\u00f6ny\u00a0B, Penzien\u00a0JM et al. Mutations in the sepiapterin reductase gene cause a novel tetrahydrobiopterin-dependent monoamine-neurotransmitter deficiency without hyperphenylalaninemia. Am J Hum Genet 2001; 69: 269\u201377. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=11443547&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1086%2F321970","DOI":"10.1086\/321970"},{"key":"ref=35","doi-asserted-by":"crossref","unstructured":"Echenne\u00a0B, Roubertie\u00a0A, Assmann\u00a0B et al. Sepiapterin reductase deficiency: clinical presentation and evaluation of long-term therapy. Pediatr Neurol 2006; 35: 308\u201313. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=17074599&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.pediatrneurol.2006.05.006","DOI":"10.1016\/j.pediatrneurol.2006.05.006"},{"key":"ref=36","doi-asserted-by":"crossref","unstructured":"Opladen\u00a0T, Okun\u00a0JG, Burgard\u00a0P et al. Phenylalanine loading in pediatric patients with dopa-responsive dystonia: revised test protocol and pediatric cutoff values. J Inherit Metab Dis 2010; 33: 697\u2013703. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20668943&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs10545-010-9164-9","DOI":"10.1007\/s10545-010-9164-9"},{"key":"ref=37","doi-asserted-by":"crossref","unstructured":"Yeung\u00a0WL, Wong\u00a0VC, Chan\u00a0KY et al. Expanding phenotype and clinical analysis of tyrosine hydroxylase deficiency. J Child Neurol 2011; 26: 179\u201387. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=20823027&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1177%2F0883073810377014","DOI":"10.1177\/0883073810377014"},{"key":"ref=38","doi-asserted-by":"crossref","unstructured":"Furukawa\u00a0Y, Guttman\u00a0M, Wong\u00a0H et al. Serum prolactin in symptomatic and asymptomatic dopa-responsive dystonia due to a GCH1 mutation. Neurology 2003; 61: 269\u201370. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=12874420&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1212%2F01.WNL.0000073983.82532.49","DOI":"10.1212\/01.WNL.0000073983.82532.49"},{"key":"ref=39","doi-asserted-by":"crossref","unstructured":"Opladen\u00a0T, Hoffmann\u00a0GF, K\u00fchn\u00a0AA et al. Pitfalls in phenylalanine loading test in the diagnosis of dopa-responsive dystonia. Mol Genet Metab 2013; 108: 195\u20137. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=23375473&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.ymgme.2013.01.001","DOI":"10.1016\/j.ymgme.2013.01.001"},{"key":"ref=40","doi-asserted-by":"crossref","unstructured":"Opladen\u00a0T, Hoffmann\u00a0GF, Blau\u00a0N. An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia. J Inherit Metab Dis 2012; 35: 963\u201373. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22729819&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1007%2Fs10545-012-9506-x","DOI":"10.1007\/s10545-012-9506-x"},{"key":"ref=41","doi-asserted-by":"crossref","unstructured":"Chi\u00a0CS, Lee\u00a0HF, Tsai\u00a0CR. Tyrosine hydroxylase deficiency in Taiwanese infants. Pediatr Neurol 2012; 46: 77\u201382. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=22264700&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.pediatrneurol.2011.11.012","DOI":"10.1016\/j.pediatrneurol.2011.11.012"},{"key":"ref=42","unstructured":"Senter for Medisinsk genetikk og Molekyl\u00e6rmedisin HU. Norsk portal for medisinsk genetisk-genetiske analyser. https:\/\/www.genetikkportalen.no\/ (31.8.2018)."},{"key":"ref=43","doi-asserted-by":"crossref","unstructured":"Opladen\u00a0T, Cort\u00e8s-Saladelafont\u00a0E, Mastrangelo\u00a0M et al. The International Working Group on Neurotransmitter related Disorders (iNTD): A worldwide research project focused on primary and secondary neurotransmitter disorders. Mol Genet Metab Rep 2016; 9: 61\u20136. PubMed: http:\/\/www.ncbi.nlm.nih.gov\/entrez\/query.fcgi?cmd=Retrieve&db=PubMed&list_uids=27830117&dopt=Abstract, Crossref: http:\/\/dx.doi.org\/10.1016%2Fj.ymgmr.2016.09.006","DOI":"10.1016\/j.ymgmr.2016.09.006"}],"container-title":["Tidsskrift for Den norske legeforening"],"original-title":["Doparesponsive dystonier"],"language":"no","deposited":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T13:23:37Z","timestamp":1781702617000},"score":1,"resource":{"primary":{"URL":"https:\/\/tidsskriftet.no\/2018\/11\/oversiktsartikkel\/doparesponsive-dystonier"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,26]]},"references-count":43,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2018,11,27]]}},"URL":"https:\/\/doi.org\/10.4045\/tidsskr.17.0595","relation":{},"ISSN":["0029-2001","0807-7096"],"issn-type":[{"value":"0029-2001","type":"print"},{"value":"0807-7096","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,26]]}}}